Life Sciences Rush Hour - Investing, News, Risk Management and any other topic impacting the space


Insurance Pro for the Life Science Industry. I talk about all things Life Sciences including investing , risk, news, drug development and other topic that could impact the space.


Claim this podcast

Remove this podcast

Play Latest Episode:

Title: Where does the market go from here? Will retail investors sell?

Where does the market go from here? Will retail investors sell?

November 21st, 2018

We talk about the recent market turmoil and how that will impact investor actions. Will investors stick to their guns or succumb and sell if the market… Go to Episode

We changed our name and Amazon announced their new locations!

November 14th, 2018

Why we changed our name to the MattCorc Podcast. Who is taking the most risk with the Amazon headquarters, Amazon or the local/state government? What… Go to Episode

What’s the deal with GE?

November 16th, 2018

GE has seen its market cap decrease by over $200B since 2016 and it now trades at around $8. Is this the correct value or should it be higher or perhaps… Go to Episode

A $500 Million Biotech IPO. Amarin Data

November 12th, 2018

Moderna plans the biggest biotech IPO ever and we learn more about Amarin’s clinical study. Was mineral oil the best choice of placebo? Lessons we can… Go to Episode